K. Chik

Jian-Piao Cai, Kwok-Hung Chan, Cuiting Luo, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo

Dafydd G. Thomas, K. To, Jian-Piao Cai, 2021, Cell Reports Medicine.

SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters

Jian-Piao Cai, Cuiting Luo, J. Chan, 2021, Nature Communications.

Vemurafenib Inhibits Enterovirus A71 Genome Replication and Virus Assembly

Jian-Piao Cai, Cuiting Luo, J. Chan, 2022, Pharmaceuticals.

A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant

J. Chan, K. Yuen, Jie Zhou, 2022, Cell Research.

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Liyuan Liu, Yicheng Guo, K. To, 2021, Nature.

Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters

J. Chan, K. Yuen, Hongzhe Sun, 2020, Nature Microbiology.

Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system

Jian-Piao Cai, Lin-Lei Chen, J. Chan, 2020, Pharmacological Research.

Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study

O. Tsang, K. To, D. Lung, 2020, The Lancet Microbe.

Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)

K. To, Jian-Piao Cai, J. Chan, 2020, Viruses.

Structure‐based discovery of clinically approved drugs as Zika virus NS2B‐NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo

Zheng Zhu, Horacio Pérez‐Sánchez, C. Yip, 2017, Antiviral research.

A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters

K. To, Jian-Piao Cai, J. Chan, 2021, Emerging microbes & infections.

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Liyuan Liu, J. Chan, K. Yuen, 2022, Nature.

Severe fever with thrombocytopenia syndrome virus (SFTSV)-host interactome screen identifies viral nucleoprotein-associated host factors as potential antiviral targets

J. Chan, K. Yuen, H. Chu, 2021, Computational and structural biotechnology journal.

In Silico Structure-Based Design of Antiviral Peptides Targeting the Severe Fever with Thrombocytopenia Syndrome Virus Glycoprotein Gn

Jian-Piao Cai, Cuiting Luo, J. Chan, 2021, Viruses.

SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury

D. Ho, K. To, J. Chan, 2021, bioRxiv.

SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection

Man, Yeung, Zhang, 2021 .

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Liyuan Liu, Yicheng Guo, K. To, 2021, Nature.

Zika Virus Infection in Dexamethasone-immunosuppressed Mice Demonstrating Disseminated Infection with Multi-organ Involvement Including Orchitis Effectively Treated by Recombinant Type I Interferons

C. Yip, Jian-Piao Cai, Kwok-Hung Chan, 2016, EBioMedicine.

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant

J. Chan, K. Yuen, Lu Lu, 2022, Cell Research.

Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

D. Ho, K. To, J. Chan, 2021, Cell Host & Microbe.

Author Correction: SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters

Jian-Piao Cai, Cuiting Luo, J. Chan, 2022, Nature Communications.

Probable Animal-to-Human Transmission of SARS-CoV-2 Delta Variant AY.127 Causing a Pet Shop-Related COVID-19 Outbreak in Hong Kong

O. Tsang, K. To, A. Tam, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor

Jian-Piao Cai, Cuiting Luo, J. Chan, 2021, International journal of biological sciences.

Targeting SUMO Modification of the Non-Structural Protein 5 of Zika Virus as a Host-Targeting Antiviral Strategy

C. Yip, J. Chan, K. Yuen, 2019, International journal of molecular sciences.

Improved detection of Zika virus RNA in human and animal specimens by a novel, highly sensitive and specific real‐time RT‐PCR assay targeting the 5′‐untranslated region of Zika virus

C. Yip, Kwok-Hung Chan, I. Hung, 2017, Tropical medicine & international health : TM & IH.

Differential cell line susceptibility to the emerging Zika virus: implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirs

C. Yip, Jian-Piao Cai, Kwok-Hung Chan, 2016, Emerging Microbes & Infections.

SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1

K. To, K. Yuen, Xinquan Wang, 2023, Emerging microbes & infections.

Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics

Jian-Piao Cai, W. Chan, Shuofeng Yuan, 2024, Acta Pharmaceutica Sinica B.